Cenni V; Bertacchini J; Beretti F; Lattanzi G; Bavelloni A; Riccio M; Ruzzene M; Marin O; Arrigoni G; Parnaik V; Wehnert M; Maraldi NM; de Pol A; Cocco L; Marmiroli S, Lamin A Ser404 Is a Nuclear Target of Akt Phosphorylation in C2C12 Cells., «JOURNAL OF PROTEOME RESEARCH», 2008, 7, pp. 4727 - 4735 [articolo]
Suh PG; Park JI; Manzoli L; Cocco L; Peak JC; Katan M; Fukami K; Kataoka T; Yun S; Ryu SH, Multiple roles of phosphoinositide-specific phospholipase C isozymes., «BMB REPORTS», 2008, 41, pp. 415 - 434 [articolo]Open Access
Faenza I; Bregoli L; Ramazzotti G; Gaboardi G; Follo MY; Mongiorgi S; Billi AM; Manzoli L; Martelli AM; Cocco L., Nuclear phospholipase C beta1 and cellular differentiation., «FRONTIERS IN BIOSCIENCE», 2008, 13, pp. 2452 - 2463 [articolo]
Follo MY; Finelli C; Bosi C; Martinelli G; Mongiorgi S; Baccarani M; Manzoli L; Blalock WL; Martelli AM; Cocco L, PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes, «LEUKEMIA», 2008, 22, pp. 198 - 200 [articolo]
Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Martinelli G; Blalock WL; Cocco L; Martelli AM., PKR is activated in MDS patients and its subcellular localization depends on disease severity., «LEUKEMIA», 2008, 22, pp. 2267 - 2269 [articolo]
Falà F; Blalock WL; Tazzari PL; Cappellini A; Chiarini F; Martinelli G; Tafuri A; McCubrey JA; Cocco L; Martelli AM, Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami
ne (A443654) in T-cell acute lymphoblastic leukemia., «MOLECULAR PHARMACOLOGY», 2008, 74, pp. 884 - 895 [articolo]
Tazzari P.L.; Tabellini G.; Ricci F.; Papa V.; Bortul R.; Chiarini F.; Evangelisti C.; Martinelli G.; Bontadini A.; Cocco L.; McCubrey J.A.; Martelli A.M., Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor perifosine in acute myeloid leukemia cells., «CANCER RESEARCH», 2008, 68, pp. 9394 - 9403 [articolo]
Ruolo editoriale nella rivista «Advances in Enzyme Regulation», AMSTERDAM, Elsevier Publ.
Lo Vasco VR; Fabrizi C; Artico M; Cocco L; Billi AM; Fumagalli L; Manzoli FA, Expression of phosphoinositide-specific phospholipase C isoenzymes in cultured
astrocytes, «JOURNAL OF CELLULAR BIOCHEMISTRY», 2007, 100, pp. 952 - 959 [articolo]
Faenza I; Ramazzotti G; Bavelloni A; Fiume R; Gaboardi GC; Follo MY; Gilmour RS; Martelli AM; Ravid K; Cocco L, Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoter, «ENDOCRINOLOGY», 2007, 148, pp. 1108 - 1117 [articolo]
Martelli AM; Evangelisti C; Billi AM; Manzoli L; Papa V; Cocco L, Intranuclear 3'-phosphoinositide metabolism and apoptosis protection in PC12
cells, «ACTA BIO-MEDICA DE L'ATENEO PARMENSE», 2007, 78, pp. 113 - 119 [articolo]
Tazzari P.L.; Cappellini A.; Ricci F.; Evangelisti C.; Papa V.;Grafone T.;
Martinelli G.; Conte R.; Cocco L.; McCubrey J.A.; Martelli A.M., Multidrug resistance-associated protein 1 expression is under the control of
the phosphoinositide 3 kinase/Akt signal transduction network in human acute
myelogenous leukemia blasts., «LEUKEMIA», 2007, 21, pp. 427 - 438 [articolo]
Zamai L; Ponti C; Mirandola P; Gobbi G; Papa S; Galeotti L; Cocco L; Vitale M, NK cells and cancer, «JOURNAL OF IMMUNOLOGY», 2007, 178, pp. 4011 - 4016 [articolo]
Evangelisti C; Tazzari PL; Riccio M; Fiume R; Hozumi Y; Fala F; Goto K;
Manzoli L; Cocco L; Martelli AM, Nuclear diacylglycerol kinase-{zeta} is a negative regulator of cell cycle
progression in C2C12 mouse myoblasts, «THE FASEB JOURNAL», 2007, 21, pp. 3297 - 3307 [articolo]
Cocco L; Follo MY; Faenza I; Bavelloni A; Billi AM; Martelli AM; Manzoli L, Nuclear inositide signaling: An appraisal of phospholipase C beta1 behavior in myelodysplastic and leukemia cells, «ADVANCES IN ENZYME REGULATION», 2007, 47 (1), pp. 2 - 9 [articolo]
